Autopsy report · NCT00967356

AZD5985 Single Ascending Dose Study

“Terminated (halted prematurely) due to tolerability issues.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 months before it stopped.
• 72 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

AstraZeneca

Sponsor type

Industry

Conditions

Healthy

Interventions

AZD5985; Placebo

Participants

72 (planned, not actual)

Sites

1

Countries

Sweden

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.